Stefano Del Prato
#107,797
Most Influential Person Now
Researcher
Stefano Del Prato's AcademicInfluence.com Rankings
Stefano Del Pratobiology Degrees
Biology
#5774
World Rank
#8336
Historical Rank
Biotechnology
#43
World Rank
#44
Historical Rank
Molecular Biology
#553
World Rank
#566
Historical Rank
Download Badge
Biology
Stefano Del Prato's Degrees
- Bachelors Biology University of Milan
- Masters Biotechnology University of Milan
Similar Degrees You Can Earn
Why Is Stefano Del Prato Influential?
(Suggest an Edit or Addition)Stefano Del Prato's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) (1260)
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
- How Do We Define Cure of Diabetes? (2009) (896)
- Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. (2007) (787)
- Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. (2002) (621)
- COVID-19 in people with diabetes: understanding the reasons for worse outcomes (2020) (600)
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations (2016) (567)
- New-Onset Diabetes in Covid-19 (2020) (541)
- Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients (2007) (529)
- Functional and molecular defects of pancreatic islets in human type 2 diabetes. (2005) (473)
- The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia (2012) (428)
- Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion (2008) (426)
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations (2016) (361)
- Obesity and insulin resistance in humans: a dose-response study. (1990) (354)
- Intermediate metabolism in normal pregnancy and in gestational diabetes (2003) (340)
- Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. (2004) (338)
- Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients (2005) (338)
- Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials (2012) (323)
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial (2012) (315)
- Effect of linagliptin monotherapy on glycaemic control and markers of β‐cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial (2011) (314)
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin (2011) (295)
- Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man (1994) (254)
- Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance (2005) (249)
- SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study (2016) (244)
- Reducing insulin resistance with metformin: the evidence today. (2003) (225)
- Phasic insulin release and metabolic regulation in type 2 diabetes. (2002) (220)
- The importance of first‐phase insulin secretion: implications for the therapy of type 2 diabetes mellitus (2001) (215)
- Management of type 2 diabetes: new and future developments in treatment (2011) (205)
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. (2021) (196)
- Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. (2005) (196)
- Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. (2007) (195)
- Prevalence and risk factors for gestational diabetes assessed by universal screening. (2003) (194)
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. (2017) (193)
- Long‐term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add‐on therapy to metformin in patients with type 2 diabetes: 4‐year data (2015) (185)
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. (2021) (182)
- Lipotoxicity in human pancreatic islets and the protective effect of metformin. (2002) (177)
- Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. (1999) (169)
- Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. (1993) (165)
- Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial (2019) (162)
- Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. (1993) (162)
- Total Body Fat Content and Fat Topography Are Associated Differently With In Vivo Glucose Metabolism in Nonobese and Obese Nondiabetic Women (1992) (161)
- Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2022) (161)
- [Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin]. (2013) (159)
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. (2016) (157)
- Tackling hyperglycemia: a more comprehensive approach. (2006) (156)
- Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. (2004) (152)
- Insulin resistance in Cushing's syndrome. (1983) (152)
- What does postprandial hyperglycaemia mean? (2004) (150)
- A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. (2003) (150)
- Improving glucose management: Ten steps to get more patients with type 2 diabetes to glycaemic goal (2005) (149)
- In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine (2008) (145)
- Effects of glucosamine infusion on insulin secretion and insulin action in humans. (2000) (144)
- Personalized Management of Hyperglycemia in Type 2 Diabetes (2013) (139)
- Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. (1998) (138)
- Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery (2020) (136)
- Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters (2020) (133)
- The place of sulfonylureas in the therapy for type 2 diabetes mellitus. (2006) (128)
- Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance (2004) (127)
- Gliclazide protects human islet beta‐cells from apoptosis induced by intermittent high glucose (2007) (126)
- Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism. (2002) (126)
- Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. (2007) (125)
- Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? (2014) (125)
- An Off-the-Shelf Instant Contact Casting Device for the Management of Diabetic Foot Ulcers (2007) (123)
- Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study (2020) (123)
- Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies (2009) (121)
- Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial (2021) (119)
- Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. (1996) (118)
- Megatrials in type 2 diabetes. From excitement to frustration? (2009) (115)
- Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add‐on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin (2014) (112)
- Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? (2017) (111)
- Effect of Metformin on Insulin-Stimulated Glucose Turnover and Insulin Binding to Receptors in Type II Diabetes (1987) (111)
- Serum haptoglobin: a novel marker of adiposity in humans. (2004) (111)
- The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach (2010) (110)
- Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study (2018) (108)
- Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies (2009) (106)
- Hepatitis C Virus Infection and Human Pancreatic β-Cell Dysfunction (2005) (106)
- Beta- and alpha-cell dysfunction in type 2 diabetes. (2004) (105)
- Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. (1983) (105)
- Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients (2006) (103)
- Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance (1997) (102)
- Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers (2012) (102)
- Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief. (2003) (100)
- Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction (2012) (99)
- Forearm Nitric Oxide Balance, Vascular Relaxation, and Glucose Metabolism in NIDDM Patients (1997) (99)
- Glucose tolerance is negatively associated with circulating progenitor cell levels (2007) (99)
- Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. (2013) (97)
- Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial (2017) (96)
- Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. (1999) (96)
- Low-Grade Inflammation and Microalbuminuria in Hypertension (2004) (96)
- Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. (2004) (94)
- Bedtime Insulin/Daytime Glipizide: Effective Therapy for Sulfonylurea Failures in NIDDM (1995) (93)
- Hyperglucagonemia and insulin-mediated glucose metabolism. (1987) (93)
- The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. (2006) (92)
- Increased O‐glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic β‐cells (2004) (91)
- Cardiovascular and heart failure safety profile of vildagliptin: a meta‐analysis of 17 000 patients (2015) (90)
- Loss of early insulin secretion leads to postprandial hyperglycaemia (2003) (89)
- COVID-19, Hyperglycemia, and New-Onset Diabetes (2021) (89)
- Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences. (2008) (87)
- The beneficial effects of pancreas transplant alone on diabetic nephropathy. (2005) (86)
- Review of Methods for Detecting Glycemic Disorders. (2020) (85)
- Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study. (2010) (84)
- Effects of pancreas–kidney transplantation on diabetic retinopathy (2005) (83)
- Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM (1996) (83)
- Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. (2005) (82)
- Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial (2018) (82)
- Loss of early insulin secretion leads to postprandial hyperglycaemia (2003) (81)
- C‐reactive protein and metabolic syndrome in women with previous gestational diabetes (2007) (80)
- Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings (2014) (79)
- PANCREAS PRESERVATION WITH UNIVERSITY OF WISCONSIN AND CELSIOR SOLUTIONS: A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED PILOT STUDY (2004) (78)
- Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. (1996) (77)
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) (77)
- Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. (2008) (77)
- Insulin Resistance Is Independently Associated With Postprandial Alterations of Triglyceride-Rich Lipoproteins in Type 2 Diabetes Mellitus (2004) (77)
- The pancreatic beta-cell in human Type 2 diabetes. (2006) (76)
- ß‐cell function and anti‐diabetic pharmacotherapy (2007) (75)
- Gemfibrozil improves insulin sensitivity and flow‐mediated vasodilatation in type 2 diabetic patients (2001) (75)
- New forms of insulin and insulin therapies for the treatment of type 2 diabetes. (2015) (73)
- Identification of cathepsin K as a novel marker of adiposity in white adipose tissue (2003) (73)
- Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition. (2000) (73)
- Beta-cell failure in type 2 diabetes mellitus. (2008) (73)
- Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2‐year study (2014) (72)
- Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells. (2004) (72)
- ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. (2006) (72)
- Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. (1991) (71)
- Hepatitis C virus infection and human pancreatic beta-cell dysfunction. (2005) (69)
- Normal Glucose Tolerance and Gestational Diabetes Mellitus (2007) (66)
- Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects (2000) (66)
- Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man (1999) (65)
- Treating the metabolic syndrome (2007) (64)
- Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome. (2004) (63)
- Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management (2014) (63)
- Concomitance of diabetic retinopathy and proteinuria accelerates the rate of decline of kidney function in type 2 diabetic patients. (2002) (62)
- Insulin resistance and diabetes mellitus. (1996) (61)
- G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids. (2010) (60)
- Metabolic Syndrome and Vascular Alterations in Normotensive Subjects at Risk of Diabetes Mellitus (2008) (59)
- Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea (2013) (59)
- Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L). (2018) (58)
- Treatment of patients over 64 years of age with type 2 diabetes: experience from nateglinide pooled database retrospective analysis. (2003) (57)
- Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. (1982) (56)
- Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials. (2015) (56)
- Cystatin C as a marker of renal function immediately after liver transplantation (2006) (56)
- Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study. (2017) (54)
- In search of normoglycaemia in diabetes: controlling postprandial glucose (2002) (54)
- Left ventricular function in normotensive young adults with well-controlled type 1 diabetes mellitus. (2007) (53)
- Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management (2007) (53)
- Metabolic memory and individual treatment aims in type 2 diabetes--outcome-lessons learned from large clinical trials. (2011) (52)
- Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study. (2012) (52)
- Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes. (2009) (52)
- β-cell failure in type 2 diabetes mellitus (2008) (51)
- A simplified technique for the en bloc procurement of abdominal organs that is suitable for pancreas and small-bowel transplantation. (2004) (51)
- Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. (2007) (50)
- Maternal Metabolic Control and Perinatal Outcome in Women With Gestational Diabetes Mellitus Treated With Lispro or Aspart Insulin (2007) (49)
- Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice (2016) (48)
- Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists (2015) (48)
- Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women. (2005) (48)
- In search of normoglycaemia in diabetes: controlling postprandial glucose (2002) (48)
- Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment (2014) (47)
- Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study (2016) (47)
- beta-cell function and anti-diabetic pharmacotherapy. (2007) (47)
- Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells: evidence for differential glutathione peroxidase-1 expression. (2010) (47)
- Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance. (1996) (47)
- A Randomized Controlled Trial to Examine the Efficacy and Safety of a New Super-Oxidized Solution for the Management of Wide Postsurgical Lesions of the Diabetic Foot (2010) (46)
- Optimal therapy of type 2 diabetes: a controversial challenge (2014) (46)
- Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients1 (2003) (45)
- Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. (1996) (45)
- Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients (2012) (45)
- Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes (2009) (45)
- The Presence of Retinopathy in Patients with Secondary Diabetes Following Pancreatectomy or Chronic Pancreatitis (1983) (44)
- Effects of exendin‐4 on islets from type 2 diabetes patients (2008) (44)
- Multidrug Treatment of Type 2 Diabetes (2011) (44)
- Linagliptin for the treatment of type 2 diabetes. (2011) (43)
- Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents (2013) (43)
- Alcohol impairs insulin sensitivity in normal subjects. (1987) (43)
- The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method. (2019) (43)
- Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin (2013) (42)
- Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction? (2013) (42)
- Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. (1998) (42)
- Insulin Sensitivity, Binding, and Kinetics in Pancreatogenic and Type I Diabetes (1982) (41)
- Continually high insulin levels impair Akt phosphorylation and glucose transport in human myoblasts. (2005) (41)
- Immune Checkpoint Blockade Anti–PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome (2019) (40)
- Changing the Treatment Paradigm for Type 2 Diabetes (2009) (40)
- Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. (2012) (40)
- Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial (2019) (40)
- β‐Cell mass plasticity in type 2 diabetes (2004) (40)
- Pre-pregnancy obesity, gestational diabetes or gestational weight gain: Which is the strongest predictor of pregnancy outcomes? (2018) (39)
- Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study. (2008) (39)
- High blood ketone body concentration in Type 2 non-insulin dependent diabetic patients (1996) (39)
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis (2022) (39)
- Individualized glycaemic targets and pharmacotherapy in type 2 diabetes (2013) (38)
- Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes. (2007) (38)
- Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury. (2016) (38)
- Harmony Outcomes: A randomized, double‐blind, placebo‐controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus—Rationale, design, and baseline characteristics (2018) (38)
- Insulin regulation of glucose and lipid metabolism in massive obesity (1990) (38)
- Early Subclinical Atherosclerosis in Women With Previous Gestational Diabetes Mellitus (2008) (37)
- Modulation of palmitic acid‐induced cell death by ergothioneine: Evidence of an anti‐inflammatory action (2008) (37)
- Type 1 diabetes and COVID-19: The “lockdown effect” (2020) (37)
- Long‐term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose‐lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24‐week phase III trials followed by a 78‐week open‐label extension (2012) (37)
- A physiological simulation model of the glucose-insulin system (1999) (37)
- Physical activity, depressed mood and pregnancy worries in European obese pregnant women: results from the DALI study (2015) (36)
- The role of adipokines in the pathogenesis of gestational diabetes mellitus (2019) (35)
- Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study (2019) (35)
- Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus (2017) (35)
- Reconstructing the rate of appearance of subcutaneous insulin by deconvolution. (1987) (35)
- Beliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus: An Explorative Study (2016) (34)
- Gestational diabetes, inflammation, and late vascular disease (2007) (34)
- Insulin degludec improves long‐term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal‐bolus insulin therapy (2015) (34)
- Reinterpreting Cardiorenal Protection of Renal Sodium–Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming (2019) (34)
- Pathogenetic Mechanisms and Cardiovascular Risk Differences between HbA 1 c and oral glucose tolerance test for the diagnosis of glucose tolerance (2012) (33)
- Ethanol impairs insulin-mediated glucose uptake by an indirect mechanism. (1996) (33)
- Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management. (2007) (33)
- Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial. (2001) (31)
- Pathogenetic Mechanisms and Cardiovascular Risk (2012) (31)
- Dipeptidyl peptidase‐4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes (2015) (31)
- Gender difference in diabetes-associated risk of first-ever and recurrent ischemic stroke. (2015) (31)
- Early improvement of unstable diabetic retinopathy after solitary pancreas transplantation. (2002) (30)
- Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study (2018) (30)
- Grain and Bean Lysates Improve Function of Endothelial Progenitor Cells from Human Peripheral Blood: Involvement of the Endogenous Antioxidant Defenses (2014) (30)
- Basal plasma insulin levels exert a qualitative but not quantitative effect on glucose-mediated glucose uptake. (1995) (29)
- PPARG2 Pro12Ala and ADAMTS9 rs4607103 as “insulin resistance loci” and “insulin secretion loci” in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 (2013) (29)
- Metformin and free fatty acid metabolism. (1995) (28)
- Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose. (1993) (28)
- Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients (2003) (28)
- Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men (2007) (28)
- Insulin resistance and lipid disorders (2008) (28)
- The non-peptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity (2009) (28)
- Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients. (1993) (28)
- Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk (2017) (27)
- The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets. (2004) (27)
- Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. (1990) (27)
- Universal screening and intensive metabolic management of gestational diabetes: cost-effectiveness in Italy (2002) (27)
- Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes (2017) (26)
- Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot. (2002) (26)
- Optimizing management of metabolic syndrome to reduce risk: focus on life-style (2008) (26)
- Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients. (2011) (26)
- Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. (2011) (25)
- Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial (2021) (25)
- Selective screening for GDM in Italy: application and effectiveness of National Guidelines (2015) (25)
- In vivo Glucose Metabolism in Obese and Type II Diabetic Subjects With or Without Hypertension (1993) (25)
- 40th EASD Annual Meeting of the European Association for the Study of Diabetes (2004) (25)
- Megatrials in type 2 diabetes. From excitement to frustration? (2009) (25)
- In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy (2003) (25)
- The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. (1981) (24)
- Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial. (2018) (24)
- Serum IgG subclasses and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schoenlein purpura. (1989) (24)
- New‐onset diabetes after kidney transplantation (2005) (24)
- Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome. (2008) (24)
- Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome (2008) (24)
- A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells (2017) (24)
- Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future (2021) (24)
- Disappearance of nephrotic syndrome in type 1 diabetic patients following pancreas transplant alone. (2006) (23)
- Microalbuminuria, a parameter independent of metabolic influences in hypertensive men (2003) (23)
- Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double‐blind, active‐controlled, parallel group, multinational clinical trial (2015) (23)
- The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats (1992) (23)
- Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels. (2003) (23)
- Pharmacological intervention in prediabetes: considering the risks and benefits (2007) (23)
- The metabolic syndrome is related to albuminuria in Type 2 diabetes (2008) (23)
- Measurement of insulin resistance in vivo. (1999) (23)
- Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? (2021) (22)
- Research: Treatment Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard-of-care metformin monotherapy—the VERIFY trial: a randomized double-blind trial (2014) (22)
- Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials. (2016) (22)
- Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients (2004) (22)
- Regulation of amino acid metabolism by epinephrine. (1990) (21)
- What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management (2009) (21)
- FIRI: fasting or false insulin resistance index? (1996) (21)
- The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes (2012) (21)
- Physical activity and dietary habits during pregnancy: effects on glucose tolerance (2010) (21)
- Effect of diabetes on hospitalization for ischemic stroke and related in‐hospital mortality: a study in Tuscany, Italy, over years 2004–2011 (2015) (20)
- Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. (1983) (20)
- Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy (2021) (20)
- The vascular effects of doxazosin in hypertension complicated by metabolic syndrome (2005) (20)
- From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes (2021) (20)
- Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people: A position statement of Primary Care Diabetes Europe. (2019) (20)
- Glucose control: closing the gap between guidelines and practice (2006) (20)
- Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. (1999) (20)
- α-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria (2006) (19)
- Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies (2019) (19)
- Targeting insulin resistance and beta-cell dysfunction: the role of thiazolidinediones. (2004) (19)
- Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: pooled analysis of data from three placebo-controlled phase III trials. (2013) (19)
- Prescribing exercise for prevention and treatment of gestational diabetes: review of suggested recommendations (2017) (19)
- Short‐term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives (1993) (19)
- Unresectable hepatocellular carcinoma in cirrhosis (1996) (19)
- Sulfonylureas and hypoglycaemia. (2002) (19)
- Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome (2019) (19)
- Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors. (2007) (18)
- Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial. (2017) (18)
- Freestyle Libre trend arrows for the management of adults with insulin-treated diabetes: A practical approach. (2019) (18)
- Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy (2011) (18)
- In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension. (1993) (18)
- Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion. (1990) (18)
- The addition of E (Empowerment and Economics) to the ABCD algorithm in diabetes care. (2015) (18)
- What therapy do our NIDDM patients need? Insulin releasers. (1995) (17)
- GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach (2015) (17)
- Effects of C‐peptide on isolated human pancreatic islet cells (2007) (17)
- Kidney and pancreas transplants in Jehovah's witnesses: ethical and practical implications. (2004) (17)
- Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol (2020) (17)
- Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme (2018) (17)
- Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant. (2015) (17)
- Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. (2022) (17)
- Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies (2021) (16)
- Gender difference in diabetes related excess risk of cardiovascular events: When does the 'risk window' open? (2017) (16)
- Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes (2014) (16)
- ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension. (2006) (16)
- Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy (1983) (16)
- Metabolic Syndrome (2015) (16)
- Optimizing Insulin Glargine Plus One Injection of Insulin Glulisine in Type 2 Diabetes in the ELEONOR Study (2011) (15)
- Practical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors (2017) (15)
- Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis (2021) (15)
- Enhanced Responsiveness of Blood Pressure to Sodium Intake and to Angiotensin II Is Associated With Insulin Resistance in IDDM Patients With Mcroalbuminuria (1998) (15)
- Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors? (2020) (15)
- Gender effect on the relation between diabetes and hospitalization for heart failure. (2012) (15)
- Chlorthalidone Improves Endothelial-Mediated Vascular Responses in Hypertension Complicated by Nondiabetic Metabolic Syndrome (2005) (15)
- Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line (2017) (15)
- Invited review. Series: Implications of the recent CVOTs in type 2 diabetes: Which patients for GLP-1RA or SGLT-2 inhibitor? (2020) (15)
- A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus (2017) (15)
- Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. (1988) (15)
- Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients. (1996) (15)
- The metabolic syndrome. Beyond the insulin resistance syndrome. (2006) (14)
- Soluble CD40 ligand levels in essential hypertensive men: evidence of a possible role of insulin resistance. (2009) (14)
- Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents (1990) (14)
- Altered Visual Plasticity in Morbidly Obese Subjects (2019) (14)
- Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post‐hoc analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin (2018) (14)
- Ketone Body Metabolism in NIDDM: Effect of Sulfonylurea Treatment (1992) (14)
- Hepatic sensitivity to insulin: effects of sulfonylurea drugs. (1991) (14)
- Rosiglitazone plus metformin: combination therapy for Type 2 diabetes (2004) (13)
- Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes (2019) (13)
- Access to emergency room for hypoglycaemia in people with diabetes (2015) (13)
- Differential effects of once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide and metformin on pancreatic β‐cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes (2016) (13)
- Circulating endothelial progenitor cells in women with gestational alterations of glucose tolerance (2011) (13)
- Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients. (2001) (13)
- Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study (2020) (13)
- MEALTIME GLUCOSE REGULATION IN TYPE 2 DIABETES (2001) (13)
- Beneficial Effect of the Nonpeptidyl Low Molecular Weight Radical Scavenger IAC on Cultured Human Islet Function (2008) (13)
- β-cell apoptosis in type 2 diabetes: quantitative and functional consequences (2008) (13)
- Early vs. standard screening and treatment of gestational diabetes in high-risk women - An attempt to determine relative advantages and disadvantages. (2019) (12)
- Evidence for a Role of Frataxin in Pancreatic Islets Isolated from Multi-Organ Donors with and Without Type 2 Diabetes Mellitus (2012) (12)
- Diabetes and acute bacterial skin and skin structure infections. (2021) (12)
- Rare diseases in clinical endocrinology: a taxonomic classification system (2015) (12)
- Regulation of medical devices used in diabetology in Europe: Time for reform? (2012) (12)
- Hyperglycaemia and cardiovascular risk (2003) (12)
- Mechanism(s) of the blood glucose lowering action of benfluorex. (1993) (12)
- Early Detection of Left Ventricular Dysfunction in Diabetes Mellitus Patients with Normal Ejection Fraction, Stratified by BMI: A Preliminary Speckle Tracking Echocardiography Study (2013) (12)
- High insulin levels impair intracellular receptor trafficking in human cultured myoblasts. (2007) (12)
- The incretin/glucagon system as a target for pharmacotherapy of obesity (2021) (12)
- The relationship between alanine and ketone body in vivo. (1982) (12)
- Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care. (2019) (11)
- Lack of association between TGF-beta-1 genotypes and microalbuminuria in essential hypertensive men. (2009) (11)
- Transcription factors of beta-cell differentiation and maturation in isolated human islets: effects of high glucose, high free fatty acids and type 2 diabetes. (2006) (11)
- Comparison of alogliptin and glipizide for composite endpoint of glycated haemoglobin reduction, no hypoglycaemia and no weight gain in type 2 diabetes mellitus (2016) (11)
- Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance (2010) (11)
- Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects (1987) (11)
- Italian national guidelines for the screening of gestational diabetes: Time for a critical appraisal? (2017) (11)
- Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case–control study (2010) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Personalized Therapy by Phenotype and Genotype (2016) (11)
- 1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women (2012) (11)
- Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes (2019) (11)
- Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion (2020) (11)
- Early impairment of beta-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes. (2006) (11)
- Effects of treatment with metformin and/or sitagliptin on beta‐cell function and insulin resistance in prediabetic women with previous gestational diabetes (2019) (11)
- Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study (2021) (11)
- Body composition study in the elderly: comparison between tritium dilution method and dual photon absorptiometry. (1993) (11)
- Cytochrome P450 2J2 Polymorphism in Healthy Caucasians and those with Diabetes Mellitus (2003) (10)
- Insulin Sensitivity Is Not Impaired In Mexican-American Women Without a Family History Of Diabetes (1995) (10)
- Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes (2019) (10)
- Expression and activity of CYP2E1 in circulating lymphocytes are not altered in diabetic individuals. (2005) (10)
- Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial (2017) (10)
- Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile (2009) (10)
- Basal weekly insulins: the way of the future! (2021) (10)
- Mechanisms of acute and chronic hypoglycemic action of gliclazide (2000) (10)
- A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets. (2010) (10)
- Functional and survival analysis of isolated human islets. (2010) (10)
- We have the evidence, we need to act to improve diabetes care (2007) (10)
- Effects of different insulin administrations on plasma amino acid profile in insulin-dependent diabetic patients. (1989) (9)
- Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality. (2018) (9)
- Pituitary autoimmunity in patients with diabetes mellitus and other endocrine disorders (2013) (9)
- Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes (2020) (9)
- Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40:813–820 (2017) (9)
- NINETY-FIVE PERCENT INSULIN INDEPENDENCE RATE THREE YEARS AFTER PANCREAS TRANSPLANTATION ALONE WITH PORTAL-ENTERIC DRAINAGE (2004) (9)
- Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy (2020) (9)
- Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery (2020) (9)
- A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules (2021) (9)
- Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Exploratory analyses from the LixiLan‐G trial (2020) (8)
- Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: The Cornell voltage (2000) (8)
- Doxazosin in metabolically complicated hypertension (2007) (8)
- Hospital incidental diagnosis of diabetes: A population study. (2016) (8)
- Heterogeneity of diabetes: heralding the era of precision medicine. (2019) (8)
- Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action (1995) (8)
- Is maternal educational level a risk factor for gestational diabetes in Caucasian women? (2012) (8)
- Heterogeneity of diabetes: heralding the era of precision medicine. (2019) (8)
- Single-center, open, prospective, randomized pilot study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation. (2004) (8)
- The IGFBP3/TMEM219 pathway regulates beta cell homeostasis (2022) (8)
- Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis (1980) (8)
- Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes. (2007) (7)
- Insulin discovery: A pivotal point in medical history (2021) (7)
- Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist (2020) (7)
- Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study (2020) (7)
- Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors (2021) (7)
- Linagliptin for the treatment of type 2 diabetes (2011) (7)
- Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study. (2010) (7)
- A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM (2019) (7)
- Correspondence Between the International Diabetes Federation Criteria for Metabolic Syndrome and Insulin Resistance in a Cohort of Italian Nondiabetic Caucasians (2007) (7)
- Postpartum screening for Type 2 Diabetes Mellitus in women with Gestational Diabetes: is it really performed? (2020) (7)
- Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia (2016) (7)
- Predictors of post-traumatic complication of mild brain injury in anticoagulated patients: DOACs are safer than VKAs (2021) (7)
- Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study (2020) (7)
- How conclusive is the CONCLUDE trial? (2020) (7)
- Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trials. (2016) (6)
- Review: The importance of effective early phase insulin secretion (2005) (6)
- Serum gamma‐glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation (2010) (6)
- Q192R Paraoxonase (PON)1 Polymorphism, Insulin Sensitivity, and Endothelial Function in Essential Hypertensive Men (2014) (6)
- Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy (1985) (6)
- Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening (2004) (6)
- Unlocking the opportunity of tight glycaemic control. Far from goal. (2005) (6)
- Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes (2007) (6)
- Brain effect of bariatric surgery in people with obesity (2022) (6)
- Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19? (2020) (6)
- Irbesartan has no short‐term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i‐RESPOND) (2009) (6)
- Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 Diabetes (2021) (6)
- Blood Glucose Control and Coronary Heart Disease (2010) (6)
- Solitary pancreas transplantation: preliminary findings about early reduction of proteinuria in incipient or evident diabetic type I nephropathy. (2004) (6)
- Diabetes in Pancreatitis, Pancreatectomy and Other Pancreatic Diseases (2014) (5)
- Glucotoxicity in human pancreatic islets is mediated by oxidative stress: evidence for limited defense capacity (2004) (5)
- Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508 (2014) (5)
- Is a motivational interviewing based lifestyle intervention for obese pregnant women across Europe implemented as planned? Process evaluation of the DALI study (2017) (5)
- PANCREAS PROCUREMENT FROM CADAVERIC DONORS OF MULTIPLE GRAFTS (2002) (5)
- Normal β‐cell function (2015) (5)
- How much weight are women gaining during pregnancy? An Italian cohort study (2015) (5)
- An alternative and simple method to consistently prepare viable isolated human islets for clinical transplantation. (2004) (5)
- Portal enteric-drained solitary pancreas transplantation without surveillance biopsy: is it safe? (2004) (5)
- Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab (2020) (5)
- PANCREAS TRANSPLANT ALONE IMPROVES DIABETIC NEPHROPATHY (2005) (5)
- Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge (2020) (5)
- The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelines. (1988) (4)
- Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus (2018) (4)
- Integrating medical and surgical therapies to optimize the outcomes of type 2 diabetes. (2016) (4)
- Prospectively Planned Meta-Analysis comparing Hypoglycemia Rates of Insulin Degludec with those of Insulin Glargine (2012) (4)
- Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study (2021) (4)
- Sulfonylureas in the therapy of type 2 diabetes mellitus: where do we stand today? (2006) (4)
- Introduction to the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) (2013) (4)
- Lack of association between CYP21 V281L variant and polycystic ovary syndrome in Italian women (2010) (4)
- [Integrin Beta 3 PlA1/PlA2 polimorphism does not contribute to complications in both type 1 and type 2 diabetes]. (2003) (4)
- Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes (2016) (4)
- [Mechanisms of hypoglycemic action of benfluorex]. (1992) (4)
- Simultaneous pancreas-kidney transplantation is improved by living kidney donation program. (2004) (4)
- Pancreas transplant alone. (2004) (4)
- Insulin Degludec Results in Consistently Lower Rates of Nocturnal Hypoglycemia Despite Lower FPG Levels Compared to Insulin Glargine in Seven Trials with T1DM or T2DM (2012) (4)
- Hypolipemic glucagon activity in isolated liver of genetic or acquired hypertriglyceridemic rats. (1980) (4)
- Total body fat content and fat topography are differently associated with in vivo glucose metabolism in nonobese and obese women. (1990) (3)
- Unlocking the opportunity of tight glycaemic control. Far from goal. (2005) (3)
- Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) (2016) (3)
- 35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
- Rationale for the association of sulfonylurea and insulin (1991) (3)
- Glycerophosphate acyltransferase activity in perfused liver of normal and hyperlipemic rats: Glucagon effect (1981) (3)
- Type 2 diabetes mellitus: focus on new treatments and special populations. (2007) (3)
- Use of non-nutritive-sweetened soft drink and risk of gestational diabetes. (2021) (3)
- The extracellular portion of the insulin receptor beta-subunit regulates the cellular trafficking of the insulin-insulin receptor complex. Studies on Chinese hamster ovary cells carrying the Cys 860-->Ser insulin receptor mutation. (2003) (3)
- Pathophysiology of Insulin Action in Humans (2005) (3)
- Insulin as an Early Treatment for Type 2 Diabetes (2013) (3)
- Rationale for the association of sulfonylurea and insulin. (1991) (3)
- A call to action--the UN Resolution on diabetes. (2007) (3)
- Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade (2021) (3)
- Post-prandial hyperglycaemia--the necessity for better control. (2000) (3)
- Exenatide modulates visual cortex responses (2019) (3)
- The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review (2022) (3)
- Lipotoxicity in human pancreatic islets and the effects of metformin (2001) (3)
- [Hyperglycemia and cardiovascular risk]. (2010) (3)
- Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. (1985) (3)
- Risk factors associated with postpartum impaired glucose regulation in women with previous gestational diabetes. (2021) (3)
- Dissociation between carotid artery lesions and lipid parameters in recipients of successful kidney graft. (2003) (3)
- Improvement of Basal Hepatic Glucose Production ana Fasting Hyperglycemia of Type I Diabetic Patients Treated With Human Recombinant Ultralente Insulin (1994) (3)
- A call to action – the UN Resolution on diabetes (2007) (2)
- 90-LB: Characterization of Tirzepatide-Treated patients achieving HbA1c <5.7% in the SURPASS 1-4 Trials (2022) (2)
- Intensive insulin treatment and postprandial control in Type 1 diabetes. (2005) (2)
- Exercise during pregnancy: how much active are pregnant women at risk of gestational diabetes despite few contraindications? (2020) (2)
- Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. (1997) (2)
- 149-OR: LixiLan-G: A Randomized Trial Assessing Switching to iGlarLixi vs. Continuation of Daily or Weekly GLP-1RA in T2D Inadequately Controlled by a GLP-1RA and OAD(s) (2019) (2)
- 1139-P: Influence of Screening HbA1c Levels on Glucose Control Achieved when Switching to iGlarLixi in T2D Inadequately Controlled on GLP-1RA and OAD(s) (2019) (2)
- Inhaled insulins: the present and future of diabetes therapy (2006) (2)
- Tackling hyperglycemia: a more comprehensive approach. (2006) (2)
- Fixed-ratio combination of basal insulin and GLP-1 receptor agonist: is two better than one? (2014) (2)
- Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII). (1992) (2)
- Global Call for Free Academic Movement for International Dialogue (2012) (2)
- Glucose and LDL lowering: the need for intensive therapy. (2012) (2)
- Gliclazide protects isolated human islets from apoptosis induced by intermittent high glucose: the role of oxidative stress (2005) (2)
- alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria (vol 24, pg 931, 2006) (2006) (2)
- 14th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging (AIMN) (2019) (2)
- Bariatric surgery restores visual cortical plasticity in nondiabetic subjects with obesity (2021) (2)
- S 56-S 64 β-cell apoptosis in type 2 diabetes : quantitative and functional consequences (2008) (2)
- Solitary pancreas transplantation in Wolfram syndrome. (2003) (2)
- Type 2 Diabetes Mellitus. From the start – combination therapy (2018) (2)
- The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe (2022) (2)
- The density of crown-like structures in epicardial adipose tissue could play a role in cardiovascular diseases (2022) (2)
- 1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial (2019) (2)
- Insulin degludec is superior to sitagliptin in improving glycaemic control in insulin-naïve patients with type 2 diabetes (2013) (2)
- Serum gamma-glutamyltransferase is not associated to peripheral arterial disease in type 2 diabetic patients: Cross-sectional findings. (2009) (2)
- Type 2 diabetes: insulin resistance vs. β-cell defect (2009) (2)
- Ten Years of Vildagliptin (2017) (2)
- Measurement of Insulin Resistance In Vivo (2012) (2)
- Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design (2009) (2)
- Tackling obesity during the COVID‐19 pandemic (2020) (2)
- [SGLT-2-inhibitor dapagliflozin: new treatment approach for diabetes type 2--new achievements, but also new questions!]. (2013) (1)
- MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance. (2021) (1)
- Glucose and LDL lowering: the need for intensive therapy. (2012) (1)
- Women in diabetes research: we can do better. Reply to Bonnefond A [letter] (2022) (1)
- Diabetes registries and high-quality diabetes care. (2023) (1)
- [11] ELEVATED ONE-HOUR POST-LOAD PLASMA GLUCOSE LEVELS IDENTIFIES SUBJECTS WITH NORMAL GLUCOSE TOLERANCE AND IMPAIRED β-CELL FUNCTION, INSULIN-RESISTANCE AND WORSE CARDIOVASCULAR RISK PROFILE. THE GENFIEV STUDY (2009) (1)
- Rational combination therapy for type 2 diabetes. (2019) (1)
- Function and survival of islets prepared from the pancreas of Type 2 diabetic patients (2002) (1)
- When and how to restore β-cell function? (2007) (1)
- A challenge for compliance (2011) (1)
- Type 2 diabetes management: putting theory into practice--introduction. (2003) (1)
- 921-P: Managing Trend Arrows with FGM: Effects on Glycemic Control in Type 1 Diabetic (T1DM) Subjects (2019) (1)
- Hyperinsulinism. Causes and mechanisms (1992) (1)
- Alirocumab offers superior benefits to usual care in treating high-risk patients with type 2 diabetes (2020) (1)
- 920-P: Flash Glucose Monitoring (FGM) in Real-Life: 18-Month Clinical Experience (2019) (1)
- Algorithms for Closed-Loop Glucose Control (Artificial Pancreas) in Diabetes. A Novel Noninvasive Approach for their Evaluation Based on Mathematical Modeling (1981) (1)
- Fixed-ratio combination of basal insulin and GLP-1 receptor agonist: is two better than one? (2014) (1)
- Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test (2022) (1)
- Pioglitazone protects human islets from lipotoxicity improving intracellular lipid metabolism and activating phosphoinositol-3-kinase (2004) (1)
- Use of new ADA and WHO criteria for the diagnosis of impaired fasting glycemia and diabetes in kidney graft recipients (2002) (1)
- ‘Do-it-yourself’ insulin pump. Case report (2007) (1)
- 422-P: Predictive Role of Triglyceride-Glucose Index on All-Cause Mortality and Incidence of Vascular Events in Type 2 Diabetes (T2D) : A 13-Year Follow-Up Observational Study (2022) (1)
- 175-OR: Effect of Alirocumab in Individuals with Type 2 Diabetes and High Triglycerides and Low High-Density Lipoprotein Cholesterol (2019) (1)
- [Plurimetabolic syndrome: association of diabetes, dyslipidemia, and arterial hypertension]. (1995) (1)
- [Acute and chronic complications of diabetes secondary to pancreatopathies]. (1995) (1)
- Rationale and Design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in Patients with High-Risk Diabetic Cardiomyopathy. (2022) (1)
- Introduction to the Third World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) (2011) (1)
- Type 2 diabetes mellitus: focus on new treatments and special populations (2007) (1)
- Functional and molecular effects of gliclazide and glibenclamide on isolated human islets cultured at high glucose concentration (2007) (1)
- Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade (2021) (1)
- 1817-P: Metabolic Surgery Affects Brain Glucose Metabolism, Cognitive Function, and Neuroplasticity in Humans (2019) (1)
- [Hyperinsulinism. Causes and mechanisms]. (1992) (1)
- The direct effects of exendin-4 on human non-diabetic and type 2 diabetic islets (2006) (1)
- Efpeglenatide, a Long-Acting Glucagon-Like Peptide-1 Receptor Agonist—Immunogenicity Profile Based on Preclinical and Clinical Studies (2018) (1)
- A few clinical features improve the prediction of mortality and cardiovascular outcomes in patients with type 2 diabetes. (2020) (1)
- Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] (2017) (1)
- 97-OR: Fatty Liver Index (FLI) Is an Independent Risk Factor for All-Cause Mortality and Cardiovascular Events in Type 1 Diabetes (T1D) : A 10-Year Observational Study (2022) (1)
- Unlocking the opportunity of tight glycaemic control (2005) (1)
- Epigenetic regulation of PGC-1 alpha inhuman type 2 diabetic islets and effect on insulin secretion (2007) (1)
- The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery (2022) (1)
- Diabetes Secondary to Acquired Disease to the Pancreas (2004) (1)
- Lack of evidence for the 1484insG variant at the 3'-UTR of the protein tyrosine phosphatase 1B (PTP1B) gene as a genetic determinant of diabetic nephropathy development in type 1 diabetic patients. (2004) (1)
- Edinburgh Research Explorer Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial (2017) (1)
- Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report (2021) (1)
- A SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED COMPARISON OF CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (2003) (0)
- Human EPCs and HUVECs exposed to high glucose: expression of antioxidative enzymes (2007) (0)
- Alirocumab Add-on Therapy Versus Control in Individuals with Type 2 DM and ASCVD: ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN (2018) (0)
- Pancreas trasnplant alone (PTA) in type 1 diabetic patients (T1DM): A 3-yr metabolic and diabetic complications follow-up (2006) (0)
- Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk (2017) (0)
- Review for "Effects of the SGLT2 inhibitor dapagliflozin on estimated plasma volume in patients with type 2 diabetes" (2019) (0)
- We-P11:184 Endothelial nitric oxide synthase (ENOS) GLU298ASP and T-786C gene polymorphism and metabolic syndrome in essential hypertension (2006) (0)
- Calpain 10 and the function of isolated type 2 diabetic and non-diabetic pancreatic islets (2005) (0)
- Looking for new pharmacological treatments for type 2 diabetes (2011) (0)
- Original Article: Complications The metabolic syndrome is related to albuminuria in Type 2 diabetes (2008) (0)
- Cord serum leptin concentrations in newborns of type 1 diabetic mothers (2001) (0)
- 1516-P: Microvascular Burden Predicts All-Cause Mortality, Major Vascular Outcomes, and ESRD in Type 2 Diabetes (2020) (0)
- Retinopathy: A Reply (1984) (0)
- Intra-pancreatic fat mononuclear cell infiltration: A link between visceral fat accumulation and beta-cell failure in human type 2 diabetes? (2008) (0)
- Intracellular glucose metabolism and insulin resistance in obese non-insulin dependent diabetes. Compensatory effects of hyperglycemia and hyperinsulinemia. (1990) (0)
- Th-P15:159 Lack of association between serum paraoxonase 1 activity and circulating oxidized low-density lipoprotein in type 2 diabetic patients (2006) (0)
- 1704-P: SIRT1 rs7896005 SNP and Incidence of Major Vascular Events in Type 2 Diabetes: A 13-Year, Single-Centre, Follow-Up Study (2019) (0)
- THE IMPACT OF LIVING KIDNEY DONATION ON A PROGRAM OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (2003) (0)
- CHARACTERIZATION OF HUMAN ISLETS IN POLYELECTROLYTE MULTILAYER CAPSULES (2006) (0)
- EFFECTS OF PANCREAS TRANSPLANTATION ON ADVANCED DIABETIC RETINOPATHY (2003) (0)
- G-protein-coupled receptor 40 (GPR40) expression in human pancreatic (2007) (0)
- tionship between exposure to diabetes and GGT levels are required to clarify the nature of our findings. References (2009) (0)
- We-P11:108 The association of metabolic syndrome with novel markers of atherosclerosis potentiates coronary heart disease risk in patients with type 2 diabetes (2006) (0)
- Long-term euglycemia after pancreas transplant alone (PTA) normalizes somatic and autonomic peripheral nerve function (PNF) in type I diabetic patients (DM1) (2005) (0)
- Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes (2014) (0)
- Endothelial Dysfunction is Associated with Arterial Stiffness in Hypertensive Patients with Type 2 Diabetes Mellitus (2009) (0)
- 453-P: Metabolic Syndrome Severity Score, All-Cause Mortality, and Incident Vascular Events in Type 2 Diabetes: A 13-Year, Single-Centre, Follow-Up Study (2019) (0)
- Insulin secretion defects of human type 2 diabetic islets are corrected by preculture with the radical scavenger IAC (2007) (0)
- Cyclic variation of backscatter myocardial signal in type I diabetes and in hypertension: an ultrasonic tissue characterization study (2002) (0)
- The direct effects of immunosuppressive drugs on isolated human islets (2008) (0)
- ROLE OF G-PROTEIN-COUPLED RECEPTOR 40 (GPR40) IN NON-DIABETIC AND TYPE 2 DIABETIC PANCREATIC ISLETS (2008) (0)
- SOLITARY PANCREAS TRANSPLANTATION (2003) (0)
- Preventing cardiovascular events in diabetic patients : the case of the patient with poor distal coronary targets (2015) (0)
- Improving Glycaemic Control - A Mandatory Action Calling for Effective Therapeutic Management (2006) (0)
- APOPTOSIS IN ISOLATED HUMAN PANCREATIC ISLETS (2008) (0)
- Meta-Analysis Comparing Hypoglycemia Rates of Insulin Degludec with Insulin Glargine U100 Across Clinical Trials with up to 2 Years' Duration (2016) (0)
- Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Insulin-naïve Patients with Type 2 Diabetes (2012) (0)
- The direct effects of exendin-4 on human non-diabetic isolated islets: possible use in islets transplantation (2007) (0)
- Author response for "Impact of disease duration and β-cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on GLP-1 receptor agonist therapy: Exploratory analyses from the LixiLan-G trial" (2020) (0)
- We-P11:186 Endothelial nitric oxide synthase E298D and T-786C polymorphisms do not affect post-challenge glucose and insulin in nondiabetic hypertensive men (2006) (0)
- Long-term efficacy and safety of pancreas transplant alone in type 1 diabetic patients (2008) (0)
- Psyllium administration can improve constipation and ameliorate metabolic parameters in patients with diabetes mellitus type 2. A prospective trial. (2005) (0)
- Glucose control: Glucose control: closing the gap between closing the gap between guidelines and practice (2006) (0)
- Correlation of endothelial progenitor cells with carbohydrate metabolism in prediabetic and diabetic patients (2008) (0)
- Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor (1984) (0)
- 2009 SIPREC Consensus Document — Executive Summary (2010) (0)
- COMMON POLYMORPHISM IN THE MCP-1 GENE REGULATORY REGION INFLUENCES MCP-1 EXPRESSION AND FUNCTION OF ISOLATED TYPE 2 PANCREATIC ISLETS (2010) (0)
- Insulin action in massive obesity before and after gastroplasty (1988) (0)
- UNIVERSITY OF WISCONSIN vs. CELSIOR SOLUTION IN PANCREAS PRESERVATION: A PROSPECTIVE RANDOMIZED STUDY (2003) (0)
- Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia (0)
- Treatment with Oral Drugs (2018) (0)
- PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects (2011) (0)
- Do physical activity and dietary changes mediate effects of a lifestyle intervention on gestational weight gain and glucose metabolism: Findings from the DALI randomised controlled trial (2017) (0)
- Iconography : β-cell apoptosis in type 2 diabetes: quantitative and functional consequences (2008) (0)
- EFFECTS OF SHORT TERM EXPOSURE OF ISOLATED HUMAN PANCREATIC ISLETS TO IMMUNOSUPPRESSIVE DRUGS: FUNCTIONAL AND MOLECULAR STUDIES (2006) (0)
- The alpha cell in type 2 diabetes: studies in human pancreatic islets (2006) (0)
- Durability of Glycemic Control with Dapagliflozin vs. Saxagliptin in Patients with Inadequately Controlled Type 2 Diabetes (2018) (0)
- [34] ENDOTHELIAL FUNCTION IS ASSOCIATED WITH ARTERIAL STIFFNESS IN SUBJECTS WITH TYPE 2 DIABETES (2009) (0)
- SOLITARY PANCREAS TRANSPLANTATION WITH PORTAL-ENTERIC DRAINAGE AND WITHOUT SURVEILLANCE BIOPSY (2003) (0)
- The association of alpha-1 adducin and ace polymorphisms with microalbuminuria in hypertensive men (2005) (0)
- Fasting hyper glycemia following trans-cathether arterial chemoembolization for hepatocellular carcinoma in cirrhosis. (1997) (0)
- NINETY-FIVE PERCENT INSULIN INDEPENDENCE RATE THREE YEARS AFTER PANCREAS TRANSPLANTATION WITH PORTAL-ENTERIC DRAINAGE (2004) (0)
- Ten Years of Vildagliptin. (2017) (0)
- W12.288 Independent role of insulin resistance in the development of postprandial lipid alterations in type 2 diabetes (2004) (0)
- Sodium-Glucose Transporter 1 and 2 Are Involved in the GLP-1 Release from Pancreatic Alpha Cells (2015) (0)
- Ctnnb1 gene expression is associated with impaired beta cell function of type 2 diabetic donors (2010) (0)
- IMPROVED OUTCOME OF SOLITARY PANCREAS TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS (2002) (0)
- 515-P: Nonalbuminuric Diabetic Kidney Disease in Type 1 Diabetes: Incidence of Major Vascular Outcomes over a 10-Year Follow-Up (2020) (0)
- Heterogeneity of chronic kidney disease (CKD) phenothypes in patients with type 1 diabetes mellitus (2013) (0)
- OP44 ORAL GLUCOSE LOWERING WITH LINAGLIPTIN PLUS METFORMIN COMPARED WITH LINAGLIPTIN ALONE AS INITIAL TREATMENT IN ASIAN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES AND MARKED HYPERGLYCEMIA (2014) (0)
- Ocular dominance plasticity in obese subjects can be restored by weight loss (2018) (0)
- PANCREAS PRESERVATION WITH UNIVERSITY OF WISCONSIN AND CELSIOR SOLUTION: A PROSPECTIVE RANDOMIZED STUDY (2002) (0)
- Diabetic ketoacidosis and acute pancreatitis associated with antipsychotic drugs: report of a case (2018) (0)
- 6-OR: Estimated Glucose Disposal Rate and Major Vascular Events in Type 1 Diabetes: A 10-Year Follow-Up Study (2019) (0)
- Effects of exposure to therapeutical concentrations of immunosuppressants on isolated human islets (2008) (0)
- SIMULTANEOUS PAMCREAS-KIDNEY TRANSPLANTATION IS IMPROVED BY LIVING KIDNEY DONATION PROGRAMME (2003) (0)
- Diabetes: Genes, diabetes and cardiovascular risk prediction (2009) (0)
- Inhaled insulins: the present and future of diabetes therapy (2006) (0)
- 10.29 Metabolic Syndrome and Vascular Alterations in Normotensive Patients at Risk of Diabetes Mellitus (2007) (0)
- Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients. (2023) (0)
- Fetal macrosomia and abnormal glucose challenge test in normotolerant pregnant women (2001) (0)
- Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells. Evidence for differential responses (2010) (0)
- Review for "Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: results from the DEFINE‐HF Trial" (2021) (0)
- Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history. (2022) (0)
- Metabolic effects of pancreas transplantation in diabetic patients (2002) (0)
- Divergent changes in expression of antioxidant enzymes in human EPCs and HUVECs exposed to high glucose (2008) (0)
- Effect of fasting on short‐term visual plasticity in adult humans (2022) (0)
- Lack of evidence for the 1484insG variant at 3 ' UTR of the PTP1B gene as a genetic determinant of risk for kidney disease in 1 Type diabetic patients (2002) (0)
- PANCREAS TRANSPLANTATION WITH PORTAL-ENTERIC OR SYSTEMIC-BLADDER DRAINAGE (2001) (0)
- L’altra metà.. Del diabete (2014) (0)
- Continuous subcutaneous insulin infusion in a patient with partial endocrine pancreatic graft function. (2001) (0)
- DOES INTRAPANCREATIC FAT ACCUMULATION INFLUENCE ISLETS FUNCTION AND SURVIVAL IN TYPE 2 DIABETIC PATIENTS? A STUDY WITH ISOLATED PANCREATIC ISLETS (2008) (0)
- APOPTOSIS AND PROLIFERATION IN HUMAN TYPE 2 DIABETIC ISLETS (2005) (0)
- ABNORMAL CAPILLARY PERMEABILITY AND ENDOTHELIAL VASOMOTOR FUNCTION IN HYPERTENSIVE MEN WITH ATP-III DEFINED METABOLIC SYNDROME: 4C.8 (2004) (0)
- Early Systolic dysfunction in asymptomatic type 1 diabetic patients DIABETES JUN 2006 VL 55 SU Suppl. 1 BP A153 EP A153 (2006) (0)
- 749-P: Clinically Relevant Predictors of Cardiovascular Events: Exploratory Analysis from the VERIFY Study of Initial Treatment of Type 2 Diabetes Mellitus (2022) (0)
- Clinical Study 1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in PregnantWomen (2014) (0)
- [80] FINDRISC (FINNISH DIABETES RISK SCORE): ITS USE AS A PREDICTOR OF BOTH DIABETES RISK AND CARDIOVASCULAR RISK IN AN ITALIAN POPULATION (2009) (0)
- [Metabolic effects of hyperglycemia in normal subjects and in type 1 and type 2 diabetics]. (1988) (0)
- PANCREAS TRANSPLANT ALONE: EFFECTS ON RENAL FUNCTION IN TYPE 1 DIABETIC PATIENTS. (2004) (0)
- Rational combination therapy for type 2 diabetes (2019) (0)
- De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes (2022) (0)
- Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44:1062–1069 (2021) (0)
- EFFECTS OF ALBIGLUTIDE ON TYPES AND NUMBERS OF MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE IN THE HARMONY OUTCOMES TRIAL (2023) (0)
- Insulin resistance, metabolic diseases, and diabetic complications : proceedings of the 7th European Symposium on Metabolism, Padova, September 30-October 3, 1998 (1999) (0)
- 411-P: Fibroblast Growth Factor 23 and Diabetic Kidney Disease Phenotypes in Type 2 Diabetes (2021) (0)
- Oxidative stress in isolated human pancreatic islets: possible role of frataxin (2006) (0)
- Genes, diabetes and cardiovascular risk prediction. (2009) (0)
- MACROENCAPSULATION OF HUMAN ISLETS FUNCTIONAL AND SURVIVAL STUDIES (2006) (0)
- Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report (2022) (0)
- EFFECTS OF DONORS AND PREPARATIONS CHARACTERISTICS ON INSULIN SECRETION FROM HUMAN ISLETS (2008) (0)
- SEQUENTIAL EARLY EVALUATION OF ANTI‐GAD AND ANTI‐IA2 AUTOANTIBODIES IN RECIPIENTS OF SOLITARY PANCREAS TRANSPLANTATION.: 031 (2003) (0)
- The growing clinical effect of SGLT2 inhibitors. (2023) (0)
- PANCREAS TRANSPLANTATION ALONE IN TYPE 1 DIABETIC PATIENTS (2005) (0)
- ORGANISATION AND DEVELOPMENT OF PANCREAS ALONE AND PANCREAS-KIDNEY TRANSPLANTATION PROGRAMS (2004) (0)
- EARLY IMPROVEMENT OF CARDIOVASCULAR RISK FACTORS AND CARDIAC FUNCTION AFTER SUCCESSFUL SOLITARY PANCREAS TRANSPLANTATION IN TYPE 1 DIABETES (2002) (0)
- Short sleep duration and risk of gestational diabetes (2022) (0)
- Improvement or stabilization of advanced diabetic retinopathy after pancreas transplantation (2003) (0)
- A master course on “Methodologies for Bio-Medical research in diabetes” (2013) (0)
- 1h post-load blood glucose for detection of individuals at increased risk of diabetes and cardiovascular disease. (2016) (0)
- intima-media thickening Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid (2012) (0)
- Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): a 3-year follow-up (2006) (0)
- Consensus Reports (2011) (0)
- Chapter 3 Interpretation of recent clinical trials concerning tight glycaemic control and cardiovascular risk (2011) (0)
- Effects of therapeutical concentration of immunosuppressant drugs on isolated human pancreatic islets: Functional and molecular studies (2007) (0)
- Københavns Universitet Beliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus (2018) (0)
- SIMULTANEOUS CADAVERIC PANCREAS LIVING KIDNEY TRANSPLANTATION (2003) (0)
- Independent Association of a Metabolic Syndrome Severity Score with All-Cause Mortality in Type 1 Diabetes—A 10-Year Follow-Up (2018) (0)
- Response Letter to D. Singh‐Franco et al. (2012) (0)
- 669-P: Prandial Insulin Secretion in the VERIFY Study (2021) (0)
- Endothelial progenitor cells and endothelial dysfunction in prediabetic and newly diagnosed type 2 diabetic subjects (2008) (0)
- Metabolic issues during the covid-19 pandemic: Gender difference (2021) (0)
- Abnormal glucose challenge test predicts fetal macrosomia in normotolerant pregnant women (2001) (0)
- MON-661 Association of 25-Hydroxyvitamin D Serum Levels with Markers of Glycemic Control in Diabetic and Nondiabetic Patients on Maintenance Hemodialysis (2020) (0)
- A common polymorphism in the ccl2 gene regulatory region affects mcp-1 gene expression and function of isolated non-diabetic and type 2 diabetic islets (2010) (0)
- Edinburgh Research Explorer Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol (2020) (0)
- Author response for "Early combination therapy delayed treatment escalation in newly-diagnosed young-onset type 2 diabetes - a sub-analysis of VERIFY study" (2020) (0)
- Improvement in cognitive dysfunction by high blood lactate levels during hypoglycaemia in type 1 diabetic patients. (1999) (0)
- Hyperinsulinemia and hyperdynamic circulation are detectable in prehypertensive subjects in the absence of cardiovascular remodelling: new insight from a wave intensity analysis approach (2009) (0)
- Triglyceride concentrations is a determinant of birth weight in women with normal glucose tolerance (2002) (0)
- Prognostic implications of diabetes phenotyping: new concepts for an old disease (2009) (0)
- Circulating endothelial progenitor cells (EPCs) in subjects with impaired glucose regulation (Pre-Diabetes) (2007) (0)
- Influence of severe obesity on circulating endothelial progenitor cells levels and effects of bariatric surgery (2013) (0)
- Assisted reproductive technology, risk of gestational diabetes and perinatal outcomes in singleton pregnancies. (2023) (0)
- The role of insulin treatment in type 2 diabetes. (1999) (0)
- SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all‐cause mortality, in Caucasians with type 2 diabetes: A 13‐year observational study (2022) (0)
- Microvascular Disease Burden and All-Cause Mortality in Type 1 Diabetes-A 10-Year Follow-Up Study (2018) (0)
- How do obese women with diabetes in pregnancy and gestational diabetes mellitus differ at booking (2015) (0)
- Author response for "Durability of Glycemic Control with Dapagliflozin, an SGLT2 Inhibitor, Compared with Saxagliptin, a DPP4 Inhibitor, in Patients with Inadequately Controlled Type 2 Diabetes" (2019) (0)
- SLC2A2 gene polymorphisms and human beta cell function (2008) (0)
- Effects of pioglitazone versus glyburide on endothelial function in type 2 diabetic patients with vascular complications: the SPLENDOR Study (2013) (0)
- MYCOPHENOLATE MOPHETIL AND PANCREAS TRANSPLANT ALO (2005) (0)
- Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141 (2021) (0)
- SLC2A2 gene polymorphisms and human beta cell function (2008) (0)
- SIMULTANEOUS CADAVERIC PANCREAS LIVING KIDNEY TRANSPLANTATION: THE ULTIMATE RESOURCE TO EXPAND THE DONOR POOL (2001) (0)
- The great metabolic syndrome debate (2006) (0)
- Pre-existing diabetes (PED) in liver transplant patients (LTP) (2007) (0)
- Cover image (2016) (0)
- Modulation of Dapagliflozin-Associated Genital Tract Infections by Saxagliptin—A Pooled Safety Analysis (2018) (0)
- Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial (2023) (0)
- EARLY IMPROVEMENT OF CARDIOVASCULAR RISK FACTORS AND CARDIAC FUNCTION AFTER SOLITARY PANCREAS TRANSPLANTATION (2002) (0)
- PANCREAS TRANSPLANTATION: EFFECTS ON DIABETIC RETINOPATHY. (2004) (0)
- CHANGES IN ATHEROSCLEROTIC PLAQUE BURDEN AND CORONARY FLOW RESERVE IN PATIENTS UNDERGOIG SUCCESSFUL PANCREAS OR KIDNEY-PANCREAS TRANSPLANTATION VS. PATIENTS NOT SUCCESSFULLY TRANSPLANTED. (2007) (0)
- Type 2 diabetes albuminuric and non‐albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease (2022) (0)
- The IGFBP3/TMEM219 pathway regulates beta cell homeostasis (2022) (0)
- Effect of Bariatric Surgery on Neuroplasticity in Humans (2018) (0)
- Estimated Glucose Disposal Rate as a Predictor of All-Cause Mortality in Type 1 Diabetes—A 10-Year Follow-Up Study (2018) (0)
- Insulin secretion and action affect glucose variability in the early stages of glucose intolerance (2022) (0)
- CSII IN A PATIENT WITH PARTIAL ENDOCRINE PANCREATIC GRAFT FUNCTION (2000) (0)
- Microvascular Complications Burden Affects Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-Up Study (2019) (0)
- Cognitive Function and Brain Plasticity in Obese Patients—The Impact of Bariatric Surgery (2018) (0)
- Su-S2:2 Carneades: Who is him? Or the metabolic sindrome (2006) (0)
- Metabolic Syndrome and Vascular Alterations in Normotensive Patients at Risk of Diabetes Mellitus (2007) (0)
- SUCCESSFUL SOLITARY PANCREAS TRANSPLANTATION WITH PORTAL-ENTERIC DRAINAGE FOLLOWING UNSUCCESSFUL ISLET CELL TRANSPLANTATION (2004) (0)
- Switching to iGlarLixi versus continuation of a daily or weekly glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in insufficiently controlled type 2 diabetes: A LixiLan‐G trial subgroup analysis by HbA1c and GLP‐1 RA use at screening (2021) (0)
- OBSERVATIONS Early Subclinical Atherosclerosis in Women With Previous Gestational Diabetes Mellitus (2008) (0)
- Might hypovitaminosis D aggravate endothelial dysfunction-related increases in arterial stiffness seen in patients with hypertension and type 2 diabetes? Reply to Boucher BJ [letter] (2012) (0)
- Common Variants Associated to Type 2 Diabetes in the Italian Population (2021) (0)
- Insulin secretion and gene expression in human pancreatic beta-cells after prolonged exposure to increased glucose concentrations (2003) (0)
- Highlights from International Congress (2008) (0)
- SOLITARY PANCREAS TRANSPLANTATION IMPROVES CARDIOVASCULAR RISK FACTORS AND CARDIAC FUNCTION IN TYPE 1 DIABETIC PATIENTS (2003) (0)
- Skipping breakfast changes visual processing: incretins contribution to short-term visual plasticity (2021) (0)
- The metabolic syndrome: a cultural exercise or a clinical entity? (2007) (0)
- PANCREAS TRANSPLANT ALONE (PTA) HAS BENEFICIAL EFFECTS ON ADVANCED DIABETIC COMPLICATIONS (2008) (0)
- Functional characterization of pancreatic islets isolated from Type 2 diabetic donors (2004) (0)
- Patient-reported outcomes in elderly patients with type 2 diabetes mellitus treated with dual oral therapy: a multicenter, observational study from Italy (2019) (0)
- 986-P: Evaluation of Cardiovascular Risk and All-Cause Mortality in Type 1 Diabetes: Comparison of Risk Engines in a 10-Year Follow-up (2021) (0)
- BENEFICIAL EFFECT OF EXPOSURE TO C-PEPTIDE ON ISOLATED HUMAN PANCREAS ISLETS (2005) (0)
- CARDIOVASCULAR RISK FACTORS AND CARDIAC FUNCTION IMPROVE AFTER SOLITARY PANCREAS TRANSPLANTATION.: 081 (2003) (0)
- INFLAMMATORY MICROALBUMINURIA, METABOLIC ABNORMALITIES AND CARDIOVASCULAR RISK IN NON DIABETIC HYPERTENSIVE MEN: P1.267 (2004) (0)
- 2256-PUB: Fixed-Ratio Insulin Degludec/Liraglutide (IDegLira) vs. Basal-Bolus Treatment in Type 2 Diabetic (T2DM) Patients with Diabetic Foot Ulcers (DFU) and Critical Limb Ischemia (CLI) (2019) (0)
- SAFETY AND EFFICACY OF PANCREAS TRANSPLANTATION ALONE IN TYPE 1 DIABETIC PATIENTS: EFFECTS ON METABOLIC PARAMETERS AND LATE DIABETES COMPLICATIONS (2004) (0)
- The relationship between dietary patterns and glycemic variability in people with impaired glucose tolerance. (2023) (0)
- Alpha-Adducin and angiotensin-converting enzyme polymorphisms inhypertension: evidence for a joint influence on albuminuria JOURNAL OF HYPERTENSION JUN 2006 VL 24 IS 6 BP 1217 EP 1217 (2006) (0)
- Syddansk Universitet Beliefs , Barriers , and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus (2016) (0)
- Cardiovascular risk factors in recipients of successful kidney-pancreas transplantation. (2001) (0)
- IDF2022-0918 Tirzepatide reduces serum triglyceride irrespective of fibrate use in people with T2D at high CV risk (SURPASS-4) (2023) (0)
- PANCREAS TRANSPLANT ALONE (PTA) HAS BENEFICIAL EFFECTS ON DIABETIC RETINOPATHY (2005) (0)
- Glucagon-likepeptide-1secretioninwomenwithgestational diabetesmellitusduringandafterpregnancy (2011) (0)
- Endothelial progenitor cells in subjects with pre-diabetes (2006) (0)
- DIFFERENT IMPACT OF HYPERTENSION AND TYPE 2 DIABETES ON AORTIC, CAROTID AND PERIPHERAL VASCULAR STIFFNESS: PP.10.408 (2010) (0)
- 258-OR: Sustainability of HbA1c Control of Tirzepatide vs. Insulin Glargine in People with Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4) (2022) (0)
- Glucose intolerance and diabetes in recipients of kidney graft: comparison of old and new ADA and WHO criteria. (2001) (0)
- Sporadic Colorectal Cancer: An Infectious Disease? (2007) (0)
- Progress and change. (2014) (0)
- Effects of pancreas transplantation on diabetic retinopathy (2004) (0)
- Is Maladaptive Carotid Remodeling A Feature of Type 2 Diabetes (2010) (0)
- [Physiopathologic and clinical aspects of diabetes following pancreatectomy]. (1986) (0)
- PRESERVATION OF HUMAN PANCREASES FOR ISLET PREPARATION BY UW OR CELSIOR SOLUTION (2003) (0)
- LIPOTOXICITY IN HUMAN PANCREATIC ISLETS IS MEDIATED BY OXIDATIVE STRESS: EVIDENCE OF THE PROTECTIVE ROLE OF A NON-PEPTIDYL LOW MOLECULAR WEIGHT RADICAL SCAVENGER (IAC) (2008) (0)
- 4.P.46 The role of nitric oxide in the hemodynamic disturbances of decompensated insulin-dependent diabetes mellitus (1997) (0)
- METABOLIC EFFECTS OF PANCREAS TRANSPLANTATION IN DAIBETIC PATIENTS: THE PISA EXPERIENCE (2003) (0)
- Simfibrate effects on plasma lipids and glucose tolerance in hyperlipoproteinemias (1981) (0)
- Is there a local "incretin system" in human pancreatic islets? (2008) (0)
- We-P11:23 Ace and PAI-1 insertion/deletion polymorphisms and age-related changes in pulse pressure in subjects with type 2 diabetes (2006) (0)
- ACE-INHIBITION PROTECTS PANCREATIC HUMAN ISLETS FROM GLUCOTOXICITY AND IMPROVES THE FUNCTION OF ISLETS FROM TYPE 2 DIABETIC PATIENTS (2004) (0)
- Maternal triglyceride concentrationd and newborn weight in women with normal glucose tolerance (2002) (0)
- [Local transcatheter arterial chemoembolization in the palliative treatment of inoperable hepatocellular carcinoma]. (1995) (0)
- SURGICAL COMPLICATIONS IN PANCREAS TRANSPLANTATION EFFECTS ON SURVIVAL OF PORTAL vs SYSTEMIC DRAINAGE (2005) (0)
- IMPROVED RESULTS OF SOLITARY PANCREAS TRANSPLANTATION (2001) (0)
- Intensitied Insulin Treatment with Lispro in IDDM (1998) (0)
- Rational Treatment of the “Plurimetabolic Syndrome” (1995) (0)
- Type 2 diabetes: simple, dual or multiple pathogenetic defects? (2003) (0)
- Progression of carotid artery remodeling and stiffness in hypertensive patients with or without diabetes mellitus: A cohort prospective study (2014) (0)
- Beneficial effects of a non-peptidyl low molecular weight radical scavenger on human islets (2008) (0)
- Insulin Initiation and Intensification Strategies—Effect of Case-Based Online Education on Physician Competence and Confidence (2018) (0)
- HEPATOSTEATOSIS AND ISLET ISOLATION (2006) (0)
- Altered fatty acid partitioning by PPAR activators improves glucose homeostasis: a case for PPAR-gamma and alpha-coagonists (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stefano Del Prato?
Stefano Del Prato is affiliated with the following schools:
